ACUR - Acura Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.300727
-0.039273 (-11.550880%)
As of 11:51AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.340000
Open0.320000
Bid0.000000 x 0
Ask0.000000 x 0
Day's Range0.285500 - 0.330000
52 Week Range0.285500 - 1.400000
Volume32,347
Avg. Volume13,448
Market Cap6.254M
Beta2.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 months ago

    ETFs with exposure to Acura Pharmaceuticals, Inc. : September 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Acura Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACUR-US. Comparing the performance and risk of Acura Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017
    Capital Cube3 months ago

    Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017

    Categories: Yahoo FinanceGet free summary analysis Acura Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Acura Pharmaceuticals, Inc. – Elite Pharmaceuticals, Inc., OPKO Health, Inc., Innoviva, Inc., Rigel Pharmaceuticals, Inc., Pfizer Inc., Johnson & Johnson, Aradigm Corporation, Nektar Therapeutics and Pain Therapeutics, Inc. ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of ACUR earnings conference call or presentation 15-Aug-17 12:30pm GMT

    Q2 2017 Acura Pharmaceuticals Inc Earnings Call

  • Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube7 months ago

    Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Acura Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Acura Pharmaceuticals, Inc. – Windtree Therapeutics, Inc., Innoviva, Inc., Aradigm Corporation, Johnson & Johnson, OPKO Health, Inc., Pfizer Inc., Nektar Therapeutics, Rigel Pharmaceuticals, Inc. and Pain Therapeutics, Inc. ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Acura Pharmaceuticals, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Acura Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACUR-US. Comparing the performance and risk of Acura Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017
    Capital Cube8 months ago

    Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017

    Categories: Yahoo FinanceGet free summary analysis Acura Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 3.77 million, Net Earnings of USD 1.53 million. Gross margins widened from 96.19% to 96.23% compared to the same period last year, operating (EBITDA) margins now 48.21% from -23.33%. Change in operating ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of ACUR earnings conference call or presentation 3-Apr-17 12:30pm GMT

    Q4 2016 Acura Pharmaceuticals Inc Earnings Call

  • Zacks11 months ago

    Implied Volatility Surging for Acura (ACUR) Stock Options

    Options traders are pricing in a big move for Acura (ACUR) shares as it has huge implied volatility.

  • Capital Cubelast year

    ETFs with exposure to Acura Pharmaceuticals, Inc. : December 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Acura Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACUR-US. Comparing the performance and risk of Acura Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)